Clinical Oncology

Papers
(The H4-Index of Clinical Oncology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Survival Outcomes for p16-positive Oropharyngeal Squamous Cell Carcinoma Based on Human Papillomavirus Status80
Assessing the Tolerability of Adjuvant and Neoadjuvant Chemotherapy in the Treatment of Early and Locally Advanced Breast Cancer in the Elderly Population at a UK Tertiary Cancer Centre79
RCR Meetings47
RCR Meetings43
Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults – Is There a Difference in Outcome?42
Vascular Interventions in Oncology42
OncoFlash–Research Updates in a Flash! (December 2022)41
Dosimetry in the Prediction and Reduction of Acute Skin Toxicity from the Use of Brass Bolus in Postmastectomy Chest Wall Radiotherapy Treatment40
Instant Oncology: Impower13340
OncoFlash – Research Updates in a Flash! (June 2022)39
Audit of cabozantinib outcomes for metastatic renal cell carcinoma at Norfolk and Norwich University Hospital33
An educational initiative to develop radiotherapy-specific teaching following the introduction of the oncology common stem year33
The First Use of Stereotactic Ablative Body Radiotherapy (SABR) in Extra-cranial Non-lung Oligometastatic Disease: A Single Centre32
Contact X-ray brachytherapy (CXB) for early rectal cancer: A review of outcomes from a single UK centre32
Improving Palliative Radiotherapy Training: A Multi-professional, Combined Clinical and Training Improvement Project30
The Time has Come to Say Goodbye28
Ayrshire Men Diagnosed with Locally Advanced Prostate Cancer between 2012 and 2013; How do they do?28
Switching to a Fixed-dose Combined Pertuzumab and Trastuzumab With Recombinant Human Hyaluronidase Subcutaneous Injection to Treat Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Re27
What can the Interventional Endoscopist Offer in the Management of Upper Gastrointestinal Malignancies?27
Perspectives of Healthcare Professionals on the Management and Treatment of Advanced Ovarian Cancer in the UK: Results From the KNOW-OC Survey27
OncoFlash: Research Updates in a Flash!26
Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC)25
The “real” outcome of esophageal cancer in elderly.24
Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)23
Comparative Analysis of Stereotactic Radiation Therapy and Conventional Radiation Therapy in Cancer Pain Control: A Systematic Review and Meta-Analysis23
Dose-Painting Proton Radiotherapy Guided by Functional MRI in Non-enhancing High-Grade Gliomas23
Digital Medicine in Men with Advanced Prostate Cancer – A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment23
Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity23
Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer23
0.17299890518188